ADCT vs MRNA · rev $40.1M vs rev $145.0M
ADC Therapeutics SA (ADCT) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
ADC Therapeutics SA (ADCT) is a biotechnology company listed on NYSE.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported ADCT revenue for 2026-06-30 was $40.1M. Net income was -$49.5M. Revenue was up 92.3% from 2026-03-31 to 2026-06-30. ADCT currently screens at market cap $141.2M.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
ADCT currently screens at market cap $141.2M. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the ADCT and MRNA stock pages for the full models.
Not investment advice.